Catalyst Convergence

TraderTools.pro Editorial Team · Updated November 15, 2026

TraderTools connects the events around a stock, not just the price, the filing or the headline. Catalyst Convergence shows where an FDA date, a financing risk, insider buying, a federal contract and short interest land on the same ticker, and what changed since you last looked.

What Catalyst Convergence does

Evidence and confidence

Every point carries an evidence label: primary-source fact, derived from a filing, cross-source match, probable relationship, unverified lead, stale data or conflicting sources. The score method, its weights and its known limits are published in the product and in the Data API documentation.

Who it is for

Event-driven, swing and biotech traders who want the collisions that matter, a catalyst arriving while the balance sheet is thin, or insiders buying ahead of a decision, without rebuilding the research by hand. See also the event-driven trading tools guide and the biotech trading tools guide.

Frequently asked questions

Is the Convergence Score a buy or sell signal?

No. It counts and weighs independent evidence on a ticker and explains each component. It does not predict price and is not investment advice.

Is it available through the API?

Yes. Convergence endpoints (score, stack, screens, changes, signals, contract exposure and briefs) are part of the keyed Data API.

What data does it not use?

It has no price, volume or analyst-coverage data, so it cannot screen for stocks that have not moved. Change history starts at the first daily snapshot.

See where the events line up

Research the catalyst, financing and insider context together before the market prices it in.

Explore TraderTools.pro